Climb Bio, Inc. (CLYM) Financials

CLYM Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 246.3 million 6.7 million
March 31, 2026 152.4 million 4.3 million
Dec. 31, 2025 167.7 million 7.3 million
Sept. 30, 2025 182.3 million 5.3 million

CLYM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -10.8 million 1.5 million
March 31, 2026 -14.4 million 1.6 million
Dec. 31, 2025 -15.6 million 1.0 million
Sept. 30, 2025 -12.2 million 4.0 million

CLYM Net Income

No data available :(

CLYM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 183.1 million - 1.3 million
March 31, 2026 109.6 million - 216000
Dec. 31, 2025 101.1 million - 285000
Sept. 30, 2025 86.9 million - 580000

CLYM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 76.2 million
March 31, 2026 68.2 million
Dec. 31, 2025 67.4 million
Sept. 30, 2025 68.0 million

CLYM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 260000 9.7 million 5.6 million -
March 31, 2026 - 9.3 million 5.8 million -
Dec. 31, 2025 - 13.7 million 5.5 million -
Sept. 30, 2025 109000 9.1 million 5.8 million -

CLYM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 38000
Dec. 31, 2025 - 30000
Sept. 30, 2025 - 29000

CLYM

Price: $17.02

52 week price:
1.54
17.52

Earnings Per Share: -0.82 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 937.9 million

Links: